Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age
Clinical trial NCT01150357 · COMPLETED
Trial details
- NCT number
- NCT01150357
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2014-08-01
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.